368 related articles for article (PubMed ID: 19119630)
1. [The expression of fibrillin 1 in pathologic scars and its significance].
Nie FF; Wang Q; Qin ZL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Sep; 24(5):339-42. PubMed ID: 19119630
[TBL] [Abstract][Full Text] [Related]
2. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
3. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
[TBL] [Abstract][Full Text] [Related]
4. [The expression of periostin in hyperplasic scars and the relations to TGF-beta1 and its receptors].
Wang Q; Nie FF; Zhao X; Qin ZL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 May; 23(3):229-32. PubMed ID: 17649947
[TBL] [Abstract][Full Text] [Related]
5. [Expression of thymosin beta 4 mRNA expression in keloid tissues and fibroblasts cultured from keloid and its significance].
Nie FF; Wu JQ; Qin ZL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Feb; 17(2):80-3. PubMed ID: 15698487
[TBL] [Abstract][Full Text] [Related]
6. [Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar].
Tang S; Pang S; Cao Y
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Jul; 15(4):283-5. PubMed ID: 11593607
[TBL] [Abstract][Full Text] [Related]
7. [Expression of mast cell tryptase in scar].
Gao F; Zhao Y; Feng YQ; Huo R; Xue WJ; Wang FG; Lv RR; Xue F; Li Q; Zhang J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Mar; 26(2):132-5. PubMed ID: 20540319
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.
Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ
Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683
[TBL] [Abstract][Full Text] [Related]
11. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts.
Fan SQ; Cai JL; Qin LY; Wang ZH; Liu ZZ; Sun ML
Ann Plast Surg; 2008 Mar; 60(3):299-305. PubMed ID: 18443513
[TBL] [Abstract][Full Text] [Related]
12. [The expression of SnoN in human hypertrophic scar fibroblasts and the mechanism of its participation in hypertrophic scar formation].
Kuang F; Zhang Z; Chen B; Liu CL; Zhao YY; Xu ZR; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Oct; 33(10):634-638. PubMed ID: 29056026
[No Abstract] [Full Text] [Related]
13. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between angiogenesis and expression of HO-1 of scar].
Zhu J; Luo CQ; He QY; Peng H; Zhou JD; Li P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):335-9. PubMed ID: 16045028
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of TGF-β1 in keloids and hypertrophic scars.
Abdou AG; Maraee AH; Al-Bara AM; Diab WM
Am J Dermatopathol; 2011 Feb; 33(1):84-91. PubMed ID: 20559120
[TBL] [Abstract][Full Text] [Related]
16. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
[TBL] [Abstract][Full Text] [Related]
17. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
18. Analysis of protease-activated receptor-1 and -2 in human scar formation.
Materazzi S; Pellerito S; Di Serio C; Paglierani M; Naldini A; Ardinghi C; Carraro F; Geppetti P; Cirino G; Santucci M; Tarantini F; Massi D
J Pathol; 2007 Aug; 212(4):440-9. PubMed ID: 17597495
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanism of miR-29 over TGF-β1 and COL1 in scar cells.
Bi S; Cao C; Chai LL; Li SR; Yang DY
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2512-2517. PubMed ID: 28617563
[TBL] [Abstract][Full Text] [Related]
20. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
